Neurohistopathological findings after continuous intrathecal administration of morphine or a morphine/bupivacaine mixture in cancer pain patients

Acta Anaesthesiologica Scandinavica

Volumn 41, Issue 8, 1997, Pages 1033-1038

  Wagemans, M F M ^a,b   Van Der Valk, P ^a   Spoelder, E M ^a   Zuurmond, W W A ^a   De Lange, J J ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bupivacaine; Cancer pain; Intrathecal; Morphine; Neurohistopathological findings

Indexed keywords

BUPIVACAINE; MORPHINE;

ANALGESIA; ARTICLE; CANCER PAIN; CLINICAL ARTICLE; FEMALE; GIANT CELL; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOCYTE; MALE; NEUROTOXICITY; PRIORITY JOURNAL;

EID: 0030772620     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-6576.1997.tb04832.x     Document Type: Article

References (21)

1. Arnér S, Arnér B. Differential effects of epidural morphine in the treatment of cancer-related pain. Acta Anaesthesiol Scand 1985: 29: 32-36.
2. Nitescu P, Appelgren L, Linder LE, Sjöberg M, Hultman E, Curelaru I. Epidural versus intrathecal morphine-bupivacaine: Assessment of consecutive treatments in advanced cancer pain. J Pain Symptom Manage 1990: 5: 18-26.
3. Sjöberg M, Appelgren L, Einarsson S, Hultman E, Linder LE, Nitescu P et al. Long-term intrathecal morphine and bupivacaine in 'refractory' cancer pain. I. Results from the first series of 52 patients. Acta Anaesthesiol Scand 1991: 35: 30-43.
4. Coombs DW, Fratkin JD, Meier FA, Nierenberg DW, Saunders RL. Neuropathologic lesions and CSF morphine concentrations during chronic continuous intraspinal morphine infusion. A clinical and post-mortem study. Pain 1985: 22: 337-351.
5. Sjöberg M, Karlsson PA, Nordborg C, Wallgren A, Nitescu P, Appelgren L et al. Neuropathologic findings after long-term intrathecal infusion of morphine and bupivacaine for pain treatment in cancer patients. Anesthesiology 1992: 76: 173-186.
6. Karlsson PA, Nordberg C, Sjöberg M, Nitescu P, Appelgren L, Curelaru I. Neuropathological findings after long-term intrathecal infusion of buprenorphine and bupivacaine of pain treatment in cancer patients. Eur J Pain 1994: 15: 68-76.
7. Pulford KAF, Rigney EM, Micklem KJ, Jones M, Stross WP, Gatter KC et al. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 1989: 42: 414-421.
8. Kurtin PJ, Pinkus GS. Leucocyte common antigen - a diagnostic discriminant between hematopoietic and non-hematopoietic neoplasms in paraffine sections using monoclonal antibodies: correlation with immunologic studies and ultrastructural localization. Hum Pathol 1985: 16: 353-365.
9. Hughes JT. Toxic and deficiency diseases. In: Bennington J.L. (Ed.). Pathology of the Spinal Cord. Major Problems in Pathology. Vol 6. Philadelphia: Saunders, 1978: 184-202.
10. Marcus RB, Million RR. The incidence of myelitis after irradiation of the cervical spinal cord. Int J Radiat Oncol Biol Phys 1990: 19: 3-8.
11. Abouleish E, Barmada MA, Nemoto EM. Acute and chronic effects of intrathecal morphine in monkeys. Br J Anaesth 1981: 53: 1027-1032.
12. Coombs DW, Colburn RW, Allen CD, Deroo DB, Fratkin JD. Toxicity of chronic spinal analgesia in a canine model: neuropathologic observations with dezocine lactate. Reg Anesth 1990: 15: 94-102.
13. Ready LB, Plumer MH, Haschke RH. Neurotoxicity of intrathecal local anesthetics in rabbits. Anesthesiology 1985: 63: 364-370.
14. Bahar M, Cole G, Rosen M, Vickers MD. Histopathology of the spinal cord after intrathecal cocaine, bupivacaine, lignocaine and adrenaline in the rat. Eur J Anaesthesial 1984: 1: 293-297.
15. Ravindran RS, Turner MS, Muller J. Neurologic effects of subarachnoid administration of 2-chloroprocaine-CE, bupivacaine, and low pH normal saline in dogs. Anesth Analg 1982: 61: 279-283.
16. Kroin JS, McCarthy RJ, Penn RD, Kerns JM, Ivankovich AD. The effect of chronic subarachnoid bupivacaine infusion in dogs. Anesthesiology 1987: 66: 737-742.
17. Li DF, Bahar M, Cole G, Rosen M. Neurological toxicity of the subarachnoid infusion of bupivacaine, lignocaine or 2-chloroprocaine in the rat. Br J Anaesth 1985: 57: 424-429.
18. Rosen MA, Baysinger CL, Shnider SM. Evaluation of neurotoxicity after subarachnoid injection of large volumes of local anesthetic solutions. Anesth Analg 983: 62: 802-808.
19. Sabbe MB, Grafe MR, Mjanger E, Tiseo PJ, Hill HF, Yaksh TL. Spinal delivery of sufentanil, alfentanil and morphine in dogs. Physiologic and toxicologic investigations. Anesthesiology 1994: 81: 899-920.
20. DuPen SL, Ramsey D, Chin S. Chronic epidural morphine and preservative-induced injury. Anesthesiology 1987: 67: 987-988.
21. Nitescu P, Karlsson PA, Nordborg C, Sjöberg M, Appelgren L, Linder LE et al. No signs of local neurotoxicity in cancer pain patients treated with long-term subarachnoid infusions of morphine with preservatives (sodium metabisulfite and sodium edetate) and bupivacaine. Eur J Pain 1992: 13: 76-88.